Appendix II — I — Decisions Cited — I

Ninth Edition, Revision 01.2024

[ Editor Note: Opinions of the Patent Trial and Appeal Board or its predecessor organizations (Board) made available to the public after the Board first published Standard Operating Procedure 2 in 1994 (addressing the publication of Board opinions and the designation of such opinions as precedential) that (1) expressly indicate that the opinion is binding precedent of the Board or (2) are identified as binding precedent on the Board’s Precedential opinion website ( www.uspto.gov/patents-application-process/appealing -patent-decisions/decisions-and-opinions/precedential ) are precedential and binding authority. Prior to 1994, a decision by the Board was considered binding on panels of the Board only if the opinion was authorized by the Board to be published. See Ex parte Holt, 19 USPQ2d 1211 (Bd.Pat. App. & Int. 1991).]

Editor Note: When possible, parallel citations to the United States Reports or Federal Reporter and the United States Patent Quarterly (USPQ) are provided and include pinpoint pages, if appropriate. However, decisions of the U.S. Supreme Court and the U.S. Court of Appeals for the Federal Circuit published after July 11, 2022, no longer contain a pinpoint page for the USPQ citations.

IBSA Institut Biochimique, S.A. v. Teva Pharm. USA, Inc., 966 F.3d 1374, 2020 USPQ2d 10865 (Fed. Cir. 2020) 2173.02

I.C.E. Corp. v. Armco Steel Corp., 250 F. Supp 738, 148 USPQ 537 (S.D.N.Y. 1966) 2128

ICON Health & Fitness, Inc., In re, 496 F.3d 1374, 83 USPQ2d 1746 (Fed. Cir. 2007) 2141.01(a) , 2143

Idenix Pharms. LLC v. Gilead Scis. Inc., 941 F.3d 1149, 2019 USPQ 2d 415844 (Fed. Cir. 2019) 2161.01 , 2164.01(a) , 2164.08

Idorsia Pharm., Ltd. v. Iancu, 811 Fed. App’x 650, 2020 USPQ2d 10498 (Fed. Cir. 2020) 2731

Immersion Corp. v. HTC Corp, 826 F.3d 1357, 119 USPQ 2d 1083 (Fed. Cir. 2016) 211.01(b)

Impax Labs. Inc. v. Aventis Pharm. Inc., 468 F.3d 1366, 81 USPQ2d 1001 (Fed Cir. 2006) 2121 , 2122 , 2152.02(b)

Impax Labs., Inc. v. Aventis Pharms. Inc., 545 F.3d 1312, 88 USPQ2d 1381 (Fed. Cir. 2008) 2152.02(b)

IMS Technology Inc. v. Haas Automation Inc., 206 F.3d 1422, 54 USPQ2d 1129 (Fed. Cir. 2000) 2181 , 2183 , 2184

Incandescent Lamp Patent, In re, 159 U. S. 465, 16 S. Ct. 75 (1895) 2164.02

Innova/Pure Water Inc. v. Safari Water Filtration Sys. Inc., 381 F.3d 1111, 72 USPQ2d 1001 (Fed. Cir. 2004) 2173.05(g)

Inphi Corporation v. Netlist, Inc., 805 F.3d 1350, 116 USPQ2d 2006 (Fed. Cir. 2015) 2173.05(i)

Intel Corp. v. PACT XPP Schweiz AG, 61 F.4th 1373, 2023 USPQ2d 297 (Fed. Cir. 2023) 2143

Intel Corp. v. Qualcomm Inc., 21 F.4th 784, 2021 USPQ2d 1259 (Fed. Cir. 2021) 2141

Intel Corp. v. U.S. Int'l Trade Comm’n, 946 F.2d 821, 20 USPQ2d 1161 (Fed. Cir. 1991) 2114

Intel Corp. v. VIA Tech., Inc., 319 F.3d 1537, 65 USPQ2d 1934 (Fed. Cir. 2003) 2181

Intellect Wireless v. HTC Corp., 732 F. 3d 1339, 108 USPQ2d 1563 (Fed. Cir. 2013) 2004 , 2010

Intellectual Ventures I LLC v. Capital One Bank (USA), N.A., 792 F.3d 1363, 115 USPQ2d 1636 (Fed. Cir. 2015) 2106 , 2106.04(a)(1) , 2106.05(f) , 2106.05(h)

Intellectual Ventures I LLC v. Capital One Fin. Corp., 850 F.3d 1332, 121 USPQ2d 1940 (Fed. Cir. 2017) 2106.04(a)(1) , 2106.04(a)(2) , 2106.05(f)

Intellectual Ventures I LLC v. Erie Indem. Co., 850 F.3d 1315, 121 USPQ2d 1928 (Fed. Cir. 2017) 2106.04(a)(1) , 2106.05(f) , 2106.05(g) , 2106.05(h)

Intellectual Ventures I LLC v. Symantec Corp., 838 F.3d 1307, 120 USPQ2d 1353 (Fed. Cir. 2016) 2106.04 , 2106.04(a)(1) , 2106.05 , 2106.05(a) , 2106.05(d) , 2106.05(f) , 2106.05(h)

Intellicall, Inc. v. Phonometrics, Inc., 952 F.2d 1384, 21 USPQ2d 1383 (Fed. Cir. 1992) 2111.01 , 2181

Intelligent Bio-Sys., Inc. v. Illumina Cambridge Ltd., 821 F.3d 1359, 119 USPQ2d 1171 (Fed. Cir. 2016) 2143.02

Intermountain Research and Eng’g Co. v. Hercules, Inc., 171 USPQ 577 (C.D. Cal. 1971) 2012

International Glass Co. v. United States, 408 F.2d 395, 159 USPQ 434 (Ct. Cl. 1968) 2138.03 , 2141.03

International Seaway Trading Corp. v. Walgreens Corp., 589 F.3d 1233, 93 USPQ2d 1001 (Fed. Cir. 2009) 1504.02

Internet Patents Corp. v. Active Network, Inc., 790 F.3d 1343, 115 USPQ2d 1414 (Fed. Cir. 2015) 2106.04(a)(1) , 2106.05(d) , 2106.05(f)

Interroyal Corp. v. Simmons Co., 204 USPQ 562 (S.D. N.Y. 1979) 2133.03(e)(1) , 2133.03(e)(3)

Interval Licensing LLC v. AOL, Inc., 766 F.3d 1364, 112 USPQ2d 1188 (Fed. Cir. 2014) 2173.05(b)

Intirtool, Ltd. v. Texar Corp., 369 F.3d 1289, 70 USPQ2d 1780 (Fed. Cir. 2004) 2111.02

Intra-Cellular Therapies, Inc. v. Iancu, 938 F.3d 1371, 2019 USPQ2d 350004 (Fed. Cir. 2019) 2732

Inventio AG v. Thyssenkrupp Elevator Americas Corp., 649 F.3d 1350, 99 USPQ2d 1112 (Fed. Cir. 2011) 2181

Invitrogen Corp. v. Biocrest Mfg., L.P., 327 F.3d 1364, 66 USPQ2d 1631 (Fed. Cir. 2003) 2111.03

Invitrogen Corp. v. Biocrest Manufacturing L.P., 424 F.3d 1374, 76 USPQ2d 1741 (Fed. Cir. 2005) 2133.03(a) , 2133.03(c) , 2152.02(c)

Invitrogen Corp. v. Clontech Laboratories, Inc., 429 F.3d 1052, 77 USPQ2d 1161 (Fed. Cir. 2005) 2138.04

Ionescu, Ex parte, 222 USPQ 537 (Bd. Pat. App. & Inter. 1984) 2143.03 , 2171 , 2173.06

IPXL Holdings v. Amazon.com, Inc., 430 F.2d 1377, 77 USPQ2d 1140 (Fed. Cir. 2005) 2173.05(p)

Irish, In re, 433 F.2d 1342, 167 USPQ 764 (CCPA 1970) 2136.01

Iron Grip Barbell Co., Inc. v. USA Sports, Inc., 392 F.3d 1317, 73 USPQ2d 1225 (Fed. Cir. 2004) 716.06 , 2144.05

Irons, In re, 340 F.2d 974, 144 USPQ 351 (CCPA 1965) 2107.02 , 2164.07

Isaacs, In re, 347 F.2d 889, 146 USPQ 193 (CCPA 1963) 2107.02 , 2107.03

Ishida Co. v. Taylor, 221 F.3d 1310, 55 USPQ2d 1449 (Fed. Cir. 2000) 2184

Ishizaka, Ex parte, 24 USPQ2d 1621 (Bd. Pat. App. & Inter. 1992) 716.02(b)